Categories AlphaGraphs, Earnings, Finance, LATEST

Bank of America posts EPS of 63 cents in Q2

Bank of America (BAC) reported second-quarter earnings of $6.8 billion, or $0.63 per share in Q2, topping market consensus as it managed to cut more expenses than expected. Meanwhile, the topline slid 1% and came in slightly above market expectations during the quarter at $22.6 billion. Analysts had, on an average, expected $22.3 billion. BAC shares rose about 1% in premarket trading today.

Helped by higher interest rates and strong growth in loans, net interest rate grew 6% to $11.7 billion. On the other hand, non-interest income decreased 7% to $11 billion during the second quarter.

CEO Brian Moynihan said in a statement, “We grew consumer and commercial loans; we grew deposits; we grew assets within our Merrill Edge business; we generated more net new households in Merrill Lynch; and we supported more institutional client activity — all of this while we continued to invest in our businesses and began an additional $500 million technology investment, which we intend to spend over the next several quarters, due to the benefits we received from tax reform.”

Bank of America second quarter 2018 earnings

RELATED: Bank of America Q2 earnings transcript

Revenue from its largest segment, Consumer Banking, rose 8% to $9.2 billion, as deposits improved 5% to $688 billion.

Shares of the second-largest US bank were hurt this year by the ongoing trade war between the US and China as investors remained concerned over its risk assets. Since the beginning of March, the bank’s shares have slipped over 11%, versus 3.1% improvement witnessed by S&P 500 index.

Earlier last week, rivals JPMorgan Chase (JPM), Citigroup (C) and Wells Fargo (WFC) had reported earnings.  All the three banks saw their stock decline after their results failed to meet the expectations of shareholders.

RELATED: Bank stocks JPMorgan and Citi fail to impress on earnings day

Related IG: First quarter earnings AlphaGraphic (Click to enlarge)

Bank of America Q1 2018 Earnings

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top